Monitor report highlights UK ophthalmology units as efficient and cost effective
Improving NHS productivity in elective care Monitor report out today The Royal College of Ophthalmologists (RCOphth) has worked in close collaboration with Monitor on this research, specifically to identify ways that cataract surgery and treatment for AMD can be more efficiently delivered in hospital eye services in the UK. The research covered a range of
The design and implementation of a study to investigate the effectiveness of community vs hospital eye service follow-up for patients with neovascular age-related macular degeneration with quiescent disease – (Eye Journal AOP)
The design and implementation of a study to investigate the effectiveness of community vs hospital eye service follow-up for patients with neovascular age-related macular degeneration with quiescent disease Eye advance online publication, October 9 2015. doi:10.1038/eye.2015.170 Authors: J Taylor, L J Scott, C A Rogers, A Muldrew, D O’Reilly, S Wordsworth, N Mills, R Hogg,
Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumab – (Eye Journal AOP)
Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumab Eye advance online publication, October 9 2015. doi:10.1038/eye.2015.175 Authors: T D Papakostas, L Lim, T van Zyl, J B Miller, B S Modjtahedi, C M Andreoli, D Wu, L H Young, I K Kim, D
Nasolacrimal duct intubation in the treatment of congenital nasolacrimal duct obstruction in older children – (Eye Journal AOP)
Nasolacrimal duct intubation in the treatment of congenital nasolacrimal duct obstruction in older children Eye advance online publication, October 9 2015. doi:10.1038/eye.2015.189 Authors: S Okumuş, V Öner, C Durucu, E Coşkun, Ü Aksoy, E Durucu, L Şahin & I Erbağcı
Comment on ‘Transitioning to intravitreal aflibercept following a previous treat-and-extend dosing regimen in neovascular age-related macular degeneration: 24-month results’ – (Eye Journal AOP)
Comment on ‘Transitioning to intravitreal aflibercept following a previous treat-and-extend dosing regimen in neovascular age-related macular degeneration: 24-month results’ Eye advance online publication, October 9 2015. doi:10.1038/eye.2015.190 Author: V P Dave